FMP

FMP

Enter

HRMY - Harmony Bi...

photo-url-https://images.financialmodelingprep.com/symbol/HRMY.png

Harmony Biosciences Holdings, Inc.

HRMY

NASDAQ

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.

34.32 USD

1.6 (4.66%)

Build Up Free Cash Flow

Year

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Revenue

159.74M

305.44M

437.86M

582.02M

714.73M

1.05B

1.56B

2.3B

3.39B

5B

Operating Cash Flow

-2.98M

98.56M

144.47M

219.39M

219.82M

278.12M

410.43M

605.68M

893.81M

1.32B

Cap Ex

-2M

-100.3M

-40.17M

-312k

-1.15M

-91.72M

-135.35M

-199.75M

-294.77M

-435M

Free Cash Flow

-4.99M

-1.74M

104.29M

219.07M

218.67M

186.4M

275.07M

405.93M

599.04M

884.02M

Wacc

8.69

8.69

8.69

8.69

8.69

Pv Lfcf

171.5M

232.85M

316.15M

429.25M

582.81M

Sum Pv Lfcf

1.73B

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2024 © Financial Modeling Prep